platinum has been researched along with Myocardial Infarction in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (78.57) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, R; Barragan, P; Bressollette, E; Chun-Chin, C; Hanratty, CG; Kretov, E; Lesiak, M; McEntegart, MB; Menown, I; Merkulov, E; O'Kane, P; Oldroyd, KG; Onuma, Y; Peace, A; Protopopov, A; Rocchiccioli, P; Silvestri, M; van Geuns, RJ; Wlodarczak, A | 1 |
| Batchelor, W; Beerkens, FJ; Cao, D; Dangas, G; Davis, S; Feng, Y; Gigliotti, OS; Giugliano, G; Haghighat, A; Horwitz, PA; Kandzari, DE; Lopez, M; Mehran, R; Othman, I; Sartori, S; Singh, S; Spirito, A; Subramaniam, V; Tamis, L; Vogel, B; Wang, JC | 1 |
| Boersma, E; Daemen, J; de Jaegere, PP; Diletti, R; Lemmert, ME; Regar, E; van Bommel, RJ; van Domburg, RT; van Geuns, RJ; van Mieghem, NM; Zijlstra, F | 1 |
| Allocco, DJ; Chen, J; Dawkins, KD; Fu, G; Han, Y; Hong, T; Jiang, T; Li, H; Liu, H; Pang, W; Su, X; Sun, F; Wang, H; Xu, K; Yang, Y; Yuan, Z; Zhang, J; Zhang, M | 1 |
| Allocco, DJ; Bouchard, A; Carrié, D; Dawkins, KD; Dens, J; Dubois, CL; Farah, B; Feldman, RL; Hagiwara, N; Kelly, CR; Meredith, IT; Pompili, V; Rabinowitz, A; Saito, S; Stone, GW; Teirstein, PS | 1 |
| Allocco, DJ; Christen, T; Crowley, J; Ferrario, M; Jung, W; Legrand, V; MacCarthy, P; Meredith, IT; Moreno, R; Redwood, S; Richardt, G; Schwimmbeck, P; Ungi, I; Werner, N; Zaman, A | 1 |
| Allocco, D; Aquino, M; Batchelor, W; Claessen, BE; Davis, S; Gigliotti, OS; Giugliano, G; Guedeney, P; Haghighat, A; Horwitz, PA; Kandzari, DE; Lopez, M; Mehran, R; Meredith, IT; Othman, I; Singh, S; Sorrentino, S; Tamis, L; Underwood, P; Wang, JC | 1 |
| Chen, P; Chen, W; Guan, Z; Hong, G; Lian, M; Rui, G; Wang, Y; Yang, H; Yang, Y; Zhang, D | 1 |
| De la Torre Hernandez, JM; Garcia Camarero, T; Gorria, GM; Lee, DH; Lerena, P; Sainz Laso, F; Zueco, J | 1 |
| Allocco, DJ; Calabria, P; Capodanno, D; Crowley, JJ; Dawkins, KD; Erglis, A; Gilbert, TJ; Horváth, IG; Menown, IB; Moreno, R; Tamburino, C | 1 |
| Li, Y; Qi, W; Qin, L; Song, Y; Wang, P; Wang, Y; Xuan, J | 1 |
| Elhadad, S; Fajadet, J; Hildick-Smith, D; Hovasse, T; Neumann, FJ; Petronio, S; Roberts, D; Silber, S; Spence, M; Valdés, M; Wöhrle, J; Zaman, A | 1 |
| Byrne, RA; Cassese, S; Colleran, R; de Waha, A; Fusaro, M; Giacoppo, D; Harada, Y; Kastrati, A; Kufner, S; Laugwitz, KL; Ndrepepa, G; Rheude, T; Schunkert, H; Xhepa, E | 1 |
| Orgain, ES; Yatteau, RF | 1 |
6 trial(s) available for platinum and Myocardial Infarction
| Article | Year |
|---|---|
Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomised trial.
Topics: Absorbable Implants; Chromium; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platinum; Polymers; Treatment Outcome | 2022 |
A randomised comparison of biodegradable polymer- and permanent polymer-coated platinum-chromium everolimus-eluting coronary stents in China: the EVOLVE China study.
Topics: Adolescent; Adult; Aged; China; Chromium; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platinum; Polymers; Sirolimus; Treatment Outcome; Young Adult | 2017 |
Long-Term Safety and Efficacy of Platinum Chromium Everolimus-Eluting Stents in Coronary Artery Disease: 5-Year Results From the PLATINUM Trial.
Topics: Aged; Asia; Cardiovascular Agents; Chromium Alloys; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Europe; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platinum; Proportional Hazards Models; Prosthesis Design; Risk Factors; Time Factors; Treatment Outcome; United States | 2017 |
A real all-comers randomized trial comparing Xience Prime and Promus Element stents.
Topics: Aged; Angina, Stable; Angina, Unstable; Chromium Alloys; Coronary Restenosis; Drug-Eluting Stents; Equipment Failure; Everolimus; Female; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platinum; Sirolimus; Thrombosis; Treatment Outcome | 2013 |
Twelve-month results of a prospective, multicentre trial to assess the everolimus-eluting coronary stent system (PROMUS Element): the PLATINUM PLUS all-comers randomised trial.
Topics: Adult; Aged; Aged, 80 and over; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platinum; Prospective Studies; Treatment Outcome | 2017 |
Outcomes of patients treated with durable polymer platinum-chromium everolimus-eluting stents: a meta-analysis of randomised trials.
Topics: Aged; Chromium; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platinum; Polymers; Treatment Outcome | 2017 |
8 other study(ies) available for platinum and Myocardial Infarction
| Article | Year |
|---|---|
Percutaneous Coronary Intervention in Men, Women, and Minorities With a Previous Coronary Artery Bypass Graft Surgery (from the Pooled PLATINUM Diversity and PROMUS Element Plus Registries).
Topics: Clinical Studies as Topic; Coronary Artery Bypass; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Platinum; Registries; Risk Factors; Treatment Outcome | 2023 |
The Promus Premier everolimus-eluting platinum chromium stent with durable polymer evaluated in a real world all-comer population in Rotterdam cardiology hospital (the P-SEARCH registry).
Topics: Aged; Angina, Stable; Chromium; Cohort Studies; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Netherlands; Percutaneous Coronary Intervention; Platinum; Polymers; Prospective Studies; Registries | 2017 |
Clinical outcomes in unselected patients treated with the PROMUS Element platinum-chromium, everolimus-eluting stent: Final five-year results from the PE PROVE Study.
Topics: Cardiovascular Agents; Chromium; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Europe; Everolimus; Female; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Platinum; Prospective Studies; Prosthesis Design; Registries; Risk Factors; Time Factors; Treatment Outcome | 2019 |
Small-vessel PCI outcomes in men, women, and minorities following platinum chromium everolimus-eluting stents: Insights from the pooled PLATINUM Diversity and PROMUS Element Plus Post-Approval studies.
Topics: Aged; Cardiovascular Agents; Chromium; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Everolimus; Female; Health Status Disparities; Humans; Male; Middle Aged; Minority Health; Myocardial Infarction; Observational Studies as Topic; Percutaneous Coronary Intervention; Platinum; Prosthesis Design; Race Factors; Registries; Retrospective Studies; Risk Factors; Sex Factors; Time Factors; Treatment Outcome; United States | 2019 |
A smartphone-assisted pressure-measuring-based diagnosis system for acute myocardial infarction diagnosis.
Topics: Antibodies; Biomarkers; Blood Pressure; Catalysis; Female; Humans; Hydrogen Peroxide; Male; Middle Aged; Myocardial Infarction; Nanoparticles; Platinum; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Smartphone; Static Electricity | 2019 |
One-year outcomes in unselected patients treated with a thin-strut, platinum-chromium, paclitaxel-eluting stent: primary endpoint results from the TAXUS Element European post-approval surveillance study (TE-PROVE).
Topics: Aged; Cardiovascular Diseases; Chromium; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Europe; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Percutaneous Coronary Intervention; Platinum; Product Surveillance, Postmarketing; Prospective Studies; Reoperation; Treatment Failure; Treatment Outcome; Tubulin Modulators | 2015 |
Integrative volumetric bar-chart chip for rapid and quantitative point-of-care detection of myocardial infarction biomarkers.
Topics: Antibodies, Immobilized; Antibodies, Monoclonal; Automation, Laboratory; Biomarkers; Computer-Aided Design; Creatine Kinase, MB Form; Enzyme-Linked Immunosorbent Assay; Equipment Design; Humans; Hydrophobic and Hydrophilic Interactions; Lab-On-A-Chip Devices; Limit of Detection; Metal Nanoparticles; Microscopy, Electron, Scanning; Myocardial Infarction; Myoglobin; Platinum; Point-of-Care Testing; Reproducibility of Results; Sensitivity and Specificity; Surface Properties; Troponin I | 2016 |
Bedside diagnosis of postinfarction ventricular septal defect using the hydrogen-sensitive, platinum-tipped, wire electrode.
Topics: Aged; Diagnosis, Differential; Electrocardiography; Electrodes; Electrodiagnosis; Heart Auscultation; Heart Septal Defects, Ventricular; Humans; Male; Mitral Valve Insufficiency; Myocardial Infarction; Platinum | 1972 |